Behbahani Ali
Insider trading activity for Behbahani Ali sourced from SEC EDGAR Form 4 filings.
Overview
- Company: Black Diamond Therapeutics, Inc.
- Total insider trades: 21
- Total buy volume: $0
- Total sell volume: $781K
- Last trade: Sep 21, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Behbahani Ali | BDTX Black Diamond Therapeutics, Inc. | OTHER | 7,707 | $15K |
| Aug 6, 2025 | Behbahani Ali | CRSP CRISPR Therapeutics AG | OTHER | 15 | N/A |
| Aug 6, 2025 | Behbahani Ali | CRSP CRISPR Therapeutics AG | OTHER | 60 | N/A |
| Sep 17, 2026 | Behbahani Ali | CRSP CRISPR Therapeutics AG | OTHER | 30,000 | N/A |
| Sep 17, 2026 | Behbahani Ali | CRSP CRISPR Therapeutics AG | SELL | 13,679 | $781K |
| Sep 17, 2026 | Behbahani Ali | CRSP CRISPR Therapeutics AG | OTHER | 30,000 | $420K |
| Jul 1, 2026 | Behbahani Ali | GLUE Monte Rosa Therapeutics, Inc. | OTHER | 15,000 | N/A |
| Jul 1, 2026 | Behbahani Ali | GLUE Monte Rosa Therapeutics, Inc. | OTHER | 15,000 | N/A |
| Jul 1, 2026 | Behbahani Ali | GLUE Monte Rosa Therapeutics, Inc. | OTHER | 1,000,000 | N/A |
| Jun 26, 2026 | Behbahani Ali | BDTX Black Diamond Therapeutics, Inc. | OTHER | 40,000 | N/A |
| Jun 19, 2026 | Behbahani Ali | BDTX Black Diamond Therapeutics, Inc. | OTHER | 8,961 | $15K |
| Jun 11, 2026 | Behbahani Ali | GLUE Monte Rosa Therapeutics, Inc. | OTHER | 25,800 | N/A |
| Jun 10, 2026 | Behbahani Ali | NKTX Nkarta, Inc. | OTHER | 37,000 | N/A |
| Jun 10, 2026 | Behbahani Ali | KRRO Korro Bio, Inc. | OTHER | 14,677 | N/A |
| Jun 5, 2026 | Behbahani Ali | CRSP CRISPR Therapeutics AG | OTHER | 13,000 | N/A |
| Apr 28, 2026 | Behbahani Ali | ACLX Arcellx, Inc. | OTHER | 9,174 | N/A |
| Apr 28, 2026 | Behbahani Ali | ACLX Arcellx, Inc. | OTHER | 8,011 | N/A |
| Apr 28, 2026 | Behbahani Ali | ACLX Arcellx, Inc. | OTHER | 11,459 | N/A |
| Apr 28, 2026 | Behbahani Ali | ACLX Arcellx, Inc. | OTHER | 2,706 | N/A |
| Apr 28, 2026 | Behbahani Ali | ACLX Arcellx, Inc. | OTHER | 1,925 | N/A |